Skip to Main Content Menu Search Site

Ying Kai Chan, Ph.D.

Visiting Scholars

Ying Kai Chan, Ph.D.

Chan’s research interests are at the interface of how viruses and the human immune system interact, with a focus on molecular engineering of desired viral and immune functions. He is currently working with George Church on a project at the Wyss Institute’s Synthetic Biology platform to develop safer and more efficacious AAV-based gene therapies. Kai received his Ph.D. in Microbiology and Immunobiology from Harvard University in 2015, with a certificate in Human Biology and Translational Medicine. During his Ph.D. in Michaela Gack’s lab, he uncovered a novel phosphomimetic-based mechanism that is used by dengue virus to subvert the host immune response, and engineered a live attenuated dengue virus. Prior, he received his M.S. from Stanford University and B.A., summa cum laude, from Washington University in St. Louis.

Close menu